Skip to main content

Can HbA1c levels be used as an independent marker of mortality and morbidity risk in patients with COVID19 positive swabs? - Poster

Zafar M, Randhawa R S, Hegner J, Alam S, Farooq M, Eldebri R, Barry L, Pun B, Shahbaz M, Makanjuola O A, Cuison F, Safarova D, Lawrence K, Elyasaky A, Nooredinvand H A, Periasamy M, Khanna A, Subba K, Adekunle B A, Ojofeitimi O, Morete Esteves A, Ciroi T M G, Moran S, O’Neill W, Taylor N, Muhammad T, Dashora U

East Sussex Healthcare NHS Trust

COVID-19 in Patients with Diabetes: real-world data on factors influencing outcome - Poster

Tee SA*, Devine K*, Potts A, Gibson E, Duffy C, Melville H, Panagiotou G, Bond Z, Ahmed S, Marchitelli G, Grixti L, Alderson N, Bajwa D, Barr A, Capstick R, Eid A, Hoy S, Li A, Mohammed O, Baker K, Little SA, Leech NJ. * Joint first authors. Corresponding author: suann.tee@nhs.net

Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK